Guohu Weng

446 total citations
16 papers, 350 citations indexed

About

Guohu Weng is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Guohu Weng has authored 16 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Guohu Weng's work include MicroRNA in disease regulation (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Circular RNAs in diseases (3 papers). Guohu Weng is often cited by papers focused on MicroRNA in disease regulation (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Circular RNAs in diseases (3 papers). Guohu Weng collaborates with scholars based in China. Guohu Weng's co-authors include Tao Liu, Suyue Pan, Xiaoyan Zhou, Guoshuai Yang, Dan Yu, Yanmin Song, Bo Zhou, Tao Liu, Yong Gu and Tao Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Neuroreport and IUBMB Life.

In The Last Decade

Guohu Weng

16 papers receiving 348 citations

Peers

Guohu Weng
Guohu Weng
Citations per year, relative to Guohu Weng Guohu Weng (= 1×) peers Yung-Feng Liao

Countries citing papers authored by Guohu Weng

Since Specialization
Citations

This map shows the geographic impact of Guohu Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohu Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohu Weng more than expected).

Fields of papers citing papers by Guohu Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohu Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohu Weng. The network helps show where Guohu Weng may publish in the future.

Co-authorship network of co-authors of Guohu Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Guohu Weng. A scholar is included among the top collaborators of Guohu Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohu Weng. Guohu Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wang, Wei, Chuipu Cai, Guohu Weng, et al.. (2024). Unveiling the molecular mechanisms of Danggui-Shaoyao-San against Alzheimer’s disease in APP/PS1 mice via integrating proteomic and metabolomic approaches. Alzheimer s Research & Therapy. 16(1). 251–251. 7 indexed citations
2.
Wu, Qihui, et al.. (2023). Network-based drug repurposing for potential stroke therapy. Computational and Structural Biotechnology Journal. 21. 2809–2823. 5 indexed citations
3.
Yao, Yujian, et al.. (2023). Apolipoprotein E mimetic peptide COG1410 alleviates blood‑brain barrier injury in a rat model of ischemic stroke. Molecular Medicine Reports. 27(4). 8 indexed citations
4.
Yao, Yujian, et al.. (2023). IRAK-M deficiency exacerbates dopaminergic neuronal damage in a mouse model of sub-acute Parkinson’s disease. Neuroreport. 34(9). 463–470. 2 indexed citations
5.
Weng, Guohu, et al.. (2021). LINC01123 promotes cell proliferation and migration via regulating miR-1277-5p/KLF5 axis in ox-LDL-induced vascular smooth muscle cells. Journal of Molecular Histology. 52(5). 943–953. 16 indexed citations
6.
Weng, Guohu, et al.. (2021). Tetramethylpyrazine Improves Cognitive Function of Alzheimer’s Disease Mice by Regulating SSTR4 Ubiquitination. Drug Design Development and Therapy. Volume 15. 2385–2399. 15 indexed citations
8.
Weng, Guohu, et al.. (2019). Sitagliptin promotes mitochondrial biogenesis in human SH‐SY5Y cells by increasing the expression of PGC‐1α/NRF1/TFAM. IUBMB Life. 71(10). 1515–1521. 30 indexed citations
9.
Zhou, Bo, et al.. (2018). Arctiin Prevents LPS-Induced Acute Lung Injury via Inhibition of PI3K/AKT Signaling Pathway in Mice. Inflammation. 41(6). 2129–2135. 43 indexed citations
10.
Weng, Guohu, et al.. (2017). Two novel Ni (II) complexes with two different Schiff bases: inhibiting glioma cells growth. Biomedical Research-tokyo. 28(6). 2526–2529. 1 indexed citations
11.
Liu, Tao, et al.. (2017). Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma. Cellular Physiology and Biochemistry. 44(2). 671–681. 42 indexed citations
12.
Weng, Guohu, et al.. (2017). Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme. Biochemical and Biophysical Research Communications. 486(4). 1129–1136. 30 indexed citations
13.
Weng, Guohu, et al.. (2016). The correlation of microRNA-181a and target genes with poor prognosis of glioblastoma patients. International Journal of Oncology. 49(1). 217–224. 15 indexed citations
14.
Yang, Guoshuai, Yanmin Song, Xiaoyan Zhou, et al.. (2015). MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo. Molecular Medicine Reports. 12(2). 3081–3088. 98 indexed citations
16.
Yang, Guoshuai, Yanmin Song, Xiaoyan Zhou, et al.. (2012). DNA methyltransferase 3, a target of microRNA-29c, contributes to neuronal proliferation by regulating the expression of brain-derived neurotrophic factor. Molecular Medicine Reports. 12(1). 1435–1442. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026